Dade Behring Incorporated, established with the 1997 merger of Dade International and Hoeschst AG's Behring Diagnostics unit, provides customers with clinical diagnostics technologies and services. The company focuses on the development of chemistry and immunochemistry, hemostasis, microbiology, and infectious disease diagnosis products. Its Dimension (R) systems integrate chemistry and immunochemistry testing features, streamlining laboratory processing. The company also is known for the automated Stratus (R) CS Acute Care Diagnostic System benchtop analyzer products, introduced in 1998. The firm offers clients plasma protein testing systems and the Syva (R) drug abuse testing and therapeutic drug monitoring tools. Dade Behring's MicroScan (R) products identify infectious bacteria. They also provide users with antibiotic dosage information. The firm's Infectious Disease Diagnostics (IDD) systems support hepatitis, HIV, and other virology testing operations. The company's SpecTRACK (TM) application streamlines the storage, location, and retrieval of specimen tubes. Dade Behring maintains operations in 34 countries. It employs 6,000 people. The firm serves over 25,000 customers. The company traces its roots to Behringwerke, established in 1904 by Nobel Prize winning immunologist Dr. Emil von Behring, and to the Dade Reagents Company, founded by Dr. John Elliott in 1949. Dade Behring is based in Deerfield, Illinois. The company went public in 2003. It is traded on NASDAQ. The firm had fiscal year 2005 revenues of $1.7 billion.